SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-21-000054
Filing Date
2021-11-10
Accepted
2021-11-10 07:12:20
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q howl-20210930.htm   iXBRL 10-Q 1521546
2 EX-10.1 a09302021ex101.htm EX-10.1 81390
3 EX-31.1 a09302021ex311.htm EX-31.1 9641
4 EX-31.2 a09302021ex312.htm EX-31.2 9662
5 EX-32.1 a09302021ex321.htm EX-32.1 7183
  Complete submission text file 0001785530-21-000054.txt   5290382

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20210930.xsd EX-101.SCH 27545
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT howl-20210930_cal.xml EX-101.CAL 36757
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT howl-20210930_def.xml EX-101.DEF 195491
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20210930_lab.xml EX-101.LAB 428982
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20210930_pre.xml EX-101.PRE 286570
11 EXTRACTED XBRL INSTANCE DOCUMENT howl-20210930_htm.xml XML 643577
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 211394375
SIC: 2834 Pharmaceutical Preparations